Advanced Wound Care: World Market Prospects 2013-2023
The demand for advanced wound care products is expected to rise over the next 10 years, driven by an increase in chronic wounds. This can be attributed to an aging population and an increase in lifestyle related disorders such as diabetes and obesity. Visiongain predicts the total advanced wound care market to be worth $16.3bn in 2023.
The move from traditional wound care treatment to advanced wound care started in the mid 80's, with more and more advanced products coming in to the market. Clinicians and patients now prefer advanced wound care products over traditional products, as they are more efficient in wound healing and reduce hospital stays. While moist wound care products currently dominate the market, wound care devices and biologics are witnessing strong growth. More companies, both multinationals and smaller companies are investing in R&D to make their product lines stronger. However, the growth will depend on more clinical evidence becoming available.
Visiongain's report Advanced Wound Care: World Market Prospects 2013-2023 examines the moist wound care, wound care devices and wound care biologics market with respect to the market size and the growth of leading sub segments from 2013-2023. This report also discusses the leading companies operating in this space and promising products in the pipeline. Visiongain predicts that this market will grow steadily to 2023, primarily driven by an increase in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices, and increased patient adoption of existing and newly-marketed products. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interviews with experts within the advanced wound care market. There are 115 tables and figures included. Visiongain has determined that the value of the global advanced wound care market will reach $16.3bn in 2023.
What makes this report unique?
Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 - all highlighting key business opportunities.
Why you should buy Advanced Wound Care: World Market Prospects 2013-2023
Gain an understanding of the overall advanced wound care market and the leading companies operating in this market by ordering Advanced Wound Care: World Market Prospects 2013-2023.
The move from traditional wound care treatment to advanced wound care started in the mid 80's, with more and more advanced products coming in to the market. Clinicians and patients now prefer advanced wound care products over traditional products, as they are more efficient in wound healing and reduce hospital stays. While moist wound care products currently dominate the market, wound care devices and biologics are witnessing strong growth. More companies, both multinationals and smaller companies are investing in R&D to make their product lines stronger. However, the growth will depend on more clinical evidence becoming available.
Visiongain's report Advanced Wound Care: World Market Prospects 2013-2023 examines the moist wound care, wound care devices and wound care biologics market with respect to the market size and the growth of leading sub segments from 2013-2023. This report also discusses the leading companies operating in this space and promising products in the pipeline. Visiongain predicts that this market will grow steadily to 2023, primarily driven by an increase in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices, and increased patient adoption of existing and newly-marketed products. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interviews with experts within the advanced wound care market. There are 115 tables and figures included. Visiongain has determined that the value of the global advanced wound care market will reach $16.3bn in 2023.
What makes this report unique?
Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 - all highlighting key business opportunities.
Why you should buy Advanced Wound Care: World Market Prospects 2013-2023
- 148 pages of comprehensive analysis
- 2 Exclusive Visiongain interviews with experts from-
- Derma Sciences
- Shire Regenerative Medicine
- 115 tables, charts, and graphs
- Global advanced wound care market forecast between 2012-2023
- 3 advanced wound care submarket forecasts from 2012-2023
- Moist Wound Care
- Wound Care Devices
- Wound Care Biologics
- SWOT analysis for each submarket
- Several leading companies identified and 6 profiled -
- Kinetic Concepts Inc (KCI)
- Smith & Nephew (S&N)
- Molnlycke Health Care
- ConvaTec
- Systagenix Wound Management
- Coloplast
Gain an understanding of the overall advanced wound care market and the leading companies operating in this market by ordering Advanced Wound Care: World Market Prospects 2013-2023.
1. EXECUTIVE SUMMARY
1.1 Sector Highlights
1.2 Aim, Scope and Format of this Report
1.3 Chapter Outline
1.4 Research and Analysis Method
1.5 Glossary of Terms Relating to Advanced Wound Care
2. INTRODUCTION
2.1 What is a Wound?
2.2 Wound Classification
2.2.1 Acute Wounds
2.2.2 Chronic Wounds
2.2.2.1 The Increasing Prevalence of Chronic Wounds
2.2.3 Burns
2.3 The Skin
2.4 The Phases of Wound Healing
2.4.1 The Inflammatory Phase
2.4.2 The Proliferation Phase
2.4.3 The Fibroblastic Phase
2.4.4 The Maturation Phase
2.5 Wound Care
2.5.1 Role of Wound Dressing
2.6 The History of Wound Care
2.7 Wound Care Categories
2.7.1 Traditional Wound Care
2.7.1.1 Gauze Dressings
2.7.1.2 Absorptive Dressings
2.7.1.3 Composite Dressings
2.7.1.4 Compression Therapy
2.7.1.5 Contact Layers
2.7.2 Advanced Wound Care (AWC)
2.7.2.1 Moist Wound Care (MWC)
2.7.2.1.1 Hydrocolloid Dressings
2.7.2.1.2 Foam Dressings
2.7.2.1.3 Alginate Dressings
2.7.2.1.4 Hydrogel Dressings
2.7.2.2 Wound Care Devices
2.7.2.2.1 Negative Pressure Wound Therapy (NPWT)
2.7.2.2.2 Ultrasound for wound therapy
2.7.2.3 Wound Care Biologics
2.7.2.3.1 Skin Replacement Therapies
2.7.2.3.2 Collagen Based Therapies
2.7.2.3.3 Cell Based Therapies
2.8 Regulation of Medical Devices
2.8.1 The US Regulation System
2.8.2 The European Approval and Regulation Process
3. GLOBAL ADVANCED WOUND CARE MARKET, 2011-2023
3.1 The Global Medical Devices Market, 2011
3.2 Global Wound Care Market, 2011
3.2.1 Global Wound Care Market Trends, 2011
3.2.2 Advanced Wound Care Market, 2011
3.3 Global Advanced Wound Care Market Forecast, 2012-2023
3.3.1 Global Advanced Wound Care Market Trends, 2012-2023
4. THE MOIST WOUND CARE MARKET, 2011-2023
4.1 The Moist Wound Care Market: Overview
4.2 The Moist Wound Care Market, 2011
4.3 Moist Wound Care Market Forecast, 2012-2023
4.4 The Moist Wound Care Market Segments, 2011
4.4.1 The Hydrocolloid Dressings Market
4.4.2 The Foam Dressings Market
4.4.3 The Alginate Dressings Market
4.4.4 The Hydrogel Dressings Market
4.4.5 Other MWC Dressings Market
4.4.5.1 Hydrofiber Technology, ConvaTec
4.4.5.2 Tegaderm Matrix Dressing with PHI Technology, 3M
4.4.5.3 XTRASORB, Derma Sciences
4.4.5.4 Lipido-Colloidal Technology Dressings, URGO MEDICAL
4.4.5.5 Antimicrobial Dressings
4.5 The Moist Wound Care Pipeline, 2011
4.5.1 NanoDOX, Nanotherapeutics
4.5.2 '1' Primary Wound Dressing, Phytoceuticals
4.6 SWOT Analysis of the Moist Wound Care Market, 2012-2023
4.6.1 Strengths
4.6.1.1 Established Segment of the Market
4.6.1.2 Wide Variety of Products
4.6.1.3 More Effective than Traditional Wound Care
4.6.2 Weaknesses
4.6.2.1 Less Effective than Some Devices and Biologics
4.6.2.2 Weak R&D Pipeline
4.6.3 Opportunities
4.6.3.1 Increasing Prevalence of Chronic Wounds
4.6.3.2 Cheap Alternative to Devices and Biologics
4.6.4 Threats
4.6.4.1 Emerging Technologies May be More Effective
4.6.4.2 Lack of R&D Spending will Stifle Innovation
5. WOUND CARE DEVICES MARKET, 2011-2023
5.1 Wound Care Devices Market: Overview
5.2 The Wound Care Devices Market, 2011
5.3 The Wound Care Devices Forecast, 2012-2023
5.3.1 Wound Care Devices Market, 2012-2017
5.3.2 Wound Care Devices Market, 2017-2023
5.4 The NPWT Market
5.4.1 The NPWT Market, 2011
5.4.2 Leading NPWT Devices: Product Analysis
5.4.2.1 V.A.C. Therapy (KCI)
5.4.2.2 RENASYS Systems (Smith & Nephew)
5.4.3 Other NPWT Systems, 2011
5.4.4 The NPWT Market Forecast, 2012-2017
5.4.5 The NPWT Market Forecast, 2017-2023
5.5 Ultrasound Wound Therapy Market, 2011
5.6 Other Wound Care Devices, 2011
5.6.1 Electrical Stimulation
5.6.2 Extracorporeal Shock Wave Therapy
5.7 The Wound Care Devices Pipeline
5.7.1 dermaPACE, Sanuwave Health
5.7.2 O-ACE-Sys (Ingenious Technologies Corporation)
5.7.3 Red Light Wave Therapy (Lightwave Technologies)
5.8 SWOT Analysis of the Wound Care Devices Market, 2012-2023
5.8.1 Strengths
5.8.1.1 More Effective than Other Forms of Wound Care
5.8.1.2 Constant Innovation in the Market
5.8.2 Weaknesses
5.8.2.1 Dominated by Few Large Companies
5.8.2.2 NPWT Dominates the Market
5.8.3 Opportunities
5.8.3.1 Low Cost NPWT Systems will Drive Growth
5.8.3.2 Increasing Prevalence of Chronic Wounds
5.8.4 Threats
5.8.4.1 Controversy Regarding Safety of NPWT
5.8.4.2 Ongoing Legal Battles Threaten Innovation
6. WOUND CARE BIOLOGICS MARKET, 2011-2023
6.1 Wound Care Biologics Market: Overview
6.2 Wound Care Biologics Market, 2011
6.3 The Wound Care Biologics Market Forecast, 2012-2023
6.3.1 Drivers and Restraints, 2012-2023
6.4 The Skin Replacement Market
6.4.1 The Skin Replacement Market, 2011
6.4.2 Leading Products in the Skin Replacement Market, 2011
6.4.2.1 Dermagraft, Shire Regenerative Medicine
6.4.2.2 Apligraf, Organogenesis
6.4.3 New Technologies
6.4.3.1 Spray on Skin to Treat Venous Leg Ulcers
6.4.4 Other Leading Products, 2011
6.4.5 The Skin Replacement Market Forecast, 2011-2017
6.4.6 The Skin Replacement Market Forecast, 2017-2023
6.5 Collagen Based Therapy Market
6.5.1 Collagen Based Therapy Market, 2011
6.5.2 The Collagen Based Therapy Market Forecast, 2011-2017
6.5.3 The Collagen Based Therapy Market Forecast, 2017-2023
6.6 The Cell Therapy Market
6.6.1 The Cell Therapy Market, 2011
6.6.2 The Cell Therapy Market Forecast, 2011-2017
6.6.3 The Cell Therapy Market Forecast, 2017-2023
6.7 The Biologics Pipeline
6.7.1 Stem Cells
6.7.1.1 Stem Cell Skin Gun, McGowan Institute for Regenerative Medicine at the University of Pittsburgh
6.7.1.2 Adult Stem Cells, Cryo-Cell International and the Snyder Wound Research Institute
6.7.1.3 Mesenchymal Stem Cells, Nara University, Japan
6.7.2 Artificial Skin
6.7.2.1 e-Skin, UC Berkeley
6.7.2.2 Genetically Modified Artificial Skin, University of Cincinnati
6.7.2.3 ReCell, Avita Medical
6.7.3 Automated Artificial Skin Production
6.7.3.1 The Tissue Factory, Fraunhofer Institute
6.7.4 Nanotechnology
6.7.4.1 DermaFuse, Missouri S&T and Mo-Sci Corporation
6.7.4.2 Phytochemical Tissue Bonding, Harvard University Institute of Photomedicine
6.7.4.3 Giant Unilamellar Vesicles, University of Bath
6.7.5 Collagen Based Therapy
6.7.5.1 Artificial Collagen Based Wound Care (Cornell University)
6.8 SWOT Analysis of the Wound Care Biologics Market, 2012-2023
6.8.1 Strengths
6.8.1.1 More Effective than Other Forms of Wound Care
6.8.1.2 New Technology with Constant Innovation
6.8.1.3 Strong R&D Pipeline
6.8.2 Weaknesses
6.8.2.1 Small Start-up Companies Dominate the Market
6.8.2.2 Expensive Technology
6.8.2.3 High Barriers to Entry
6.8.3 Opportunities
6.8.3.1 Strong Innovation will Drive Growth
6.8.3.2 Stem Cells Offer Multiple Opportunities
6.8.3.3 Increasing Prevalence of Chronic Wounds
6.8.3.4 Development of Diagnostic Tests
6.8.4 Threats
6.8.4.1 Controversy Regarding the Effectiveness of Some Biologics
6.8.4.2 High Barriers to Entry will Deter Competitors
6.8.4.3 Competition from MWC and Devices
7. LEADING NATIONAL ADVANCED WOUND CARE MARKET, 2011-2023
7.1 Regional Breakdown of the Global Advanced Wound Care Market, 2011
7.2 The Global Advanced Wound Care Market: Regional Forecast, 2012-2023
7.3 The US Market
7.4 The European Market
7.4.1 Germany and France
7.4.2 The UK Market
7.4.3 The Spanish Market
7.4.4 The Italian Market
7.5 The Japanese Market
7.6 The Chinese Market
7.7 The Indian Market
8. LEADING COMPANIES IN ADVANCED WOUND CARE MARKET, 2012-2023
8.1 Leading Companies, 2011
8.2 Kinetic Concepts Inc (KCI)
8.2.1 Apax Partners' Led Consortium Acquires KCI for $6.3bn
8.2.2 Success of VAC Therapy
8.2.3 KCI Expands its Operations
8.3 Smith & Nephew (S&N)
8.3.1 Sales and Performance Analysis, 2011
8.3.2 Regional Breakdown, 2011
8.3.3 Smith & Nephew Advanced Wound Care Sales. 2011
8.3.4 Advanced Wound Management Sales by Region, 2011
8.3.5 Smith & Nephew Pipeline
8.3.6 Smith & Nephew Acquires Kalypto Medical
8.4 Molnlycke Health Care
8.4.1 Molnlycke Sales, 2011
8.4.2 Recent Acquisitions
8.4.2.1 Molnlycke Acquires WoundEL from Gerromed GmbH
8.4.2.2 Molnlycke Acquires Burn and Wound Care Business of Brennen Medical
8.5 ConvaTec
8.5.1 Sales and Performance Analysis, 2011
8.5.2 ConvaTec Advanced Wound Care Sales, 2011
8.5.3 Regional Breakdown, 2011
8.5.4 ConvaTec Research & Development
8.6 Systagenix Wound Management
8.6.1 Systagenix Acquires O2 Insights Inc
8.7 Coloplast
8.7.1 Coloplast Sales and Performance Analysis, 2011
8.7.2 Regional Breakdown, 2011
8.7.3 Coloplast Advanced Wound Care Sales, 2010/2011
8.8 Other Companies, 2011
9. EXPERT OPINION
9.1 Interview with Derma Sciences
9.1.1 Perspective of Advanced Wound Care Market
9.1.2 Unmet needs of the Industry
9.1.3 Do FDA Regulations Stifle Innovation?
9.1.4 Role of Moist Wound Care in the Future
9.1.5 Market for MEDIHONEY in Moist Wound Care
9.1.6 Key Products Driving Company Growth
9.1.7 Efficacy of Honey in Comparison to Silver
9.2 Interview with Shire Regenerative Medicine
9.2.1 Perspective of Wound Care Biologics Market
9.2.2 Cost and Reimbursement Issues
9.2.3 Outlook for Dermagraft
10. ADVANCED WOUND CARE MARKET, 2012-2023
10.1 Advanced Wound Care Market, 2012-2023
10.1.1 Growth will be driven by an Increasing Prevalence of Chronic Wounds
10.1.2 Emerging Markets will Drive Growth
10.2 The Moist Wound Care Market
10.3 The Wound Care Devices Market
10.4 The Wound Care Biologics Market
1.1 Sector Highlights
1.2 Aim, Scope and Format of this Report
1.3 Chapter Outline
1.4 Research and Analysis Method
1.5 Glossary of Terms Relating to Advanced Wound Care
2. INTRODUCTION
2.1 What is a Wound?
2.2 Wound Classification
2.2.1 Acute Wounds
2.2.2 Chronic Wounds
2.2.2.1 The Increasing Prevalence of Chronic Wounds
2.2.3 Burns
2.3 The Skin
2.4 The Phases of Wound Healing
2.4.1 The Inflammatory Phase
2.4.2 The Proliferation Phase
2.4.3 The Fibroblastic Phase
2.4.4 The Maturation Phase
2.5 Wound Care
2.5.1 Role of Wound Dressing
2.6 The History of Wound Care
2.7 Wound Care Categories
2.7.1 Traditional Wound Care
2.7.1.1 Gauze Dressings
2.7.1.2 Absorptive Dressings
2.7.1.3 Composite Dressings
2.7.1.4 Compression Therapy
2.7.1.5 Contact Layers
2.7.2 Advanced Wound Care (AWC)
2.7.2.1 Moist Wound Care (MWC)
2.7.2.1.1 Hydrocolloid Dressings
2.7.2.1.2 Foam Dressings
2.7.2.1.3 Alginate Dressings
2.7.2.1.4 Hydrogel Dressings
2.7.2.2 Wound Care Devices
2.7.2.2.1 Negative Pressure Wound Therapy (NPWT)
2.7.2.2.2 Ultrasound for wound therapy
2.7.2.3 Wound Care Biologics
2.7.2.3.1 Skin Replacement Therapies
2.7.2.3.2 Collagen Based Therapies
2.7.2.3.3 Cell Based Therapies
2.8 Regulation of Medical Devices
2.8.1 The US Regulation System
2.8.2 The European Approval and Regulation Process
3. GLOBAL ADVANCED WOUND CARE MARKET, 2011-2023
3.1 The Global Medical Devices Market, 2011
3.2 Global Wound Care Market, 2011
3.2.1 Global Wound Care Market Trends, 2011
3.2.2 Advanced Wound Care Market, 2011
3.3 Global Advanced Wound Care Market Forecast, 2012-2023
3.3.1 Global Advanced Wound Care Market Trends, 2012-2023
4. THE MOIST WOUND CARE MARKET, 2011-2023
4.1 The Moist Wound Care Market: Overview
4.2 The Moist Wound Care Market, 2011
4.3 Moist Wound Care Market Forecast, 2012-2023
4.4 The Moist Wound Care Market Segments, 2011
4.4.1 The Hydrocolloid Dressings Market
4.4.2 The Foam Dressings Market
4.4.3 The Alginate Dressings Market
4.4.4 The Hydrogel Dressings Market
4.4.5 Other MWC Dressings Market
4.4.5.1 Hydrofiber Technology, ConvaTec
4.4.5.2 Tegaderm Matrix Dressing with PHI Technology, 3M
4.4.5.3 XTRASORB, Derma Sciences
4.4.5.4 Lipido-Colloidal Technology Dressings, URGO MEDICAL
4.4.5.5 Antimicrobial Dressings
4.5 The Moist Wound Care Pipeline, 2011
4.5.1 NanoDOX, Nanotherapeutics
4.5.2 '1' Primary Wound Dressing, Phytoceuticals
4.6 SWOT Analysis of the Moist Wound Care Market, 2012-2023
4.6.1 Strengths
4.6.1.1 Established Segment of the Market
4.6.1.2 Wide Variety of Products
4.6.1.3 More Effective than Traditional Wound Care
4.6.2 Weaknesses
4.6.2.1 Less Effective than Some Devices and Biologics
4.6.2.2 Weak R&D Pipeline
4.6.3 Opportunities
4.6.3.1 Increasing Prevalence of Chronic Wounds
4.6.3.2 Cheap Alternative to Devices and Biologics
4.6.4 Threats
4.6.4.1 Emerging Technologies May be More Effective
4.6.4.2 Lack of R&D Spending will Stifle Innovation
5. WOUND CARE DEVICES MARKET, 2011-2023
5.1 Wound Care Devices Market: Overview
5.2 The Wound Care Devices Market, 2011
5.3 The Wound Care Devices Forecast, 2012-2023
5.3.1 Wound Care Devices Market, 2012-2017
5.3.2 Wound Care Devices Market, 2017-2023
5.4 The NPWT Market
5.4.1 The NPWT Market, 2011
5.4.2 Leading NPWT Devices: Product Analysis
5.4.2.1 V.A.C. Therapy (KCI)
5.4.2.2 RENASYS Systems (Smith & Nephew)
5.4.3 Other NPWT Systems, 2011
5.4.4 The NPWT Market Forecast, 2012-2017
5.4.5 The NPWT Market Forecast, 2017-2023
5.5 Ultrasound Wound Therapy Market, 2011
5.6 Other Wound Care Devices, 2011
5.6.1 Electrical Stimulation
5.6.2 Extracorporeal Shock Wave Therapy
5.7 The Wound Care Devices Pipeline
5.7.1 dermaPACE, Sanuwave Health
5.7.2 O-ACE-Sys (Ingenious Technologies Corporation)
5.7.3 Red Light Wave Therapy (Lightwave Technologies)
5.8 SWOT Analysis of the Wound Care Devices Market, 2012-2023
5.8.1 Strengths
5.8.1.1 More Effective than Other Forms of Wound Care
5.8.1.2 Constant Innovation in the Market
5.8.2 Weaknesses
5.8.2.1 Dominated by Few Large Companies
5.8.2.2 NPWT Dominates the Market
5.8.3 Opportunities
5.8.3.1 Low Cost NPWT Systems will Drive Growth
5.8.3.2 Increasing Prevalence of Chronic Wounds
5.8.4 Threats
5.8.4.1 Controversy Regarding Safety of NPWT
5.8.4.2 Ongoing Legal Battles Threaten Innovation
6. WOUND CARE BIOLOGICS MARKET, 2011-2023
6.1 Wound Care Biologics Market: Overview
6.2 Wound Care Biologics Market, 2011
6.3 The Wound Care Biologics Market Forecast, 2012-2023
6.3.1 Drivers and Restraints, 2012-2023
6.4 The Skin Replacement Market
6.4.1 The Skin Replacement Market, 2011
6.4.2 Leading Products in the Skin Replacement Market, 2011
6.4.2.1 Dermagraft, Shire Regenerative Medicine
6.4.2.2 Apligraf, Organogenesis
6.4.3 New Technologies
6.4.3.1 Spray on Skin to Treat Venous Leg Ulcers
6.4.4 Other Leading Products, 2011
6.4.5 The Skin Replacement Market Forecast, 2011-2017
6.4.6 The Skin Replacement Market Forecast, 2017-2023
6.5 Collagen Based Therapy Market
6.5.1 Collagen Based Therapy Market, 2011
6.5.2 The Collagen Based Therapy Market Forecast, 2011-2017
6.5.3 The Collagen Based Therapy Market Forecast, 2017-2023
6.6 The Cell Therapy Market
6.6.1 The Cell Therapy Market, 2011
6.6.2 The Cell Therapy Market Forecast, 2011-2017
6.6.3 The Cell Therapy Market Forecast, 2017-2023
6.7 The Biologics Pipeline
6.7.1 Stem Cells
6.7.1.1 Stem Cell Skin Gun, McGowan Institute for Regenerative Medicine at the University of Pittsburgh
6.7.1.2 Adult Stem Cells, Cryo-Cell International and the Snyder Wound Research Institute
6.7.1.3 Mesenchymal Stem Cells, Nara University, Japan
6.7.2 Artificial Skin
6.7.2.1 e-Skin, UC Berkeley
6.7.2.2 Genetically Modified Artificial Skin, University of Cincinnati
6.7.2.3 ReCell, Avita Medical
6.7.3 Automated Artificial Skin Production
6.7.3.1 The Tissue Factory, Fraunhofer Institute
6.7.4 Nanotechnology
6.7.4.1 DermaFuse, Missouri S&T and Mo-Sci Corporation
6.7.4.2 Phytochemical Tissue Bonding, Harvard University Institute of Photomedicine
6.7.4.3 Giant Unilamellar Vesicles, University of Bath
6.7.5 Collagen Based Therapy
6.7.5.1 Artificial Collagen Based Wound Care (Cornell University)
6.8 SWOT Analysis of the Wound Care Biologics Market, 2012-2023
6.8.1 Strengths
6.8.1.1 More Effective than Other Forms of Wound Care
6.8.1.2 New Technology with Constant Innovation
6.8.1.3 Strong R&D Pipeline
6.8.2 Weaknesses
6.8.2.1 Small Start-up Companies Dominate the Market
6.8.2.2 Expensive Technology
6.8.2.3 High Barriers to Entry
6.8.3 Opportunities
6.8.3.1 Strong Innovation will Drive Growth
6.8.3.2 Stem Cells Offer Multiple Opportunities
6.8.3.3 Increasing Prevalence of Chronic Wounds
6.8.3.4 Development of Diagnostic Tests
6.8.4 Threats
6.8.4.1 Controversy Regarding the Effectiveness of Some Biologics
6.8.4.2 High Barriers to Entry will Deter Competitors
6.8.4.3 Competition from MWC and Devices
7. LEADING NATIONAL ADVANCED WOUND CARE MARKET, 2011-2023
7.1 Regional Breakdown of the Global Advanced Wound Care Market, 2011
7.2 The Global Advanced Wound Care Market: Regional Forecast, 2012-2023
7.3 The US Market
7.4 The European Market
7.4.1 Germany and France
7.4.2 The UK Market
7.4.3 The Spanish Market
7.4.4 The Italian Market
7.5 The Japanese Market
7.6 The Chinese Market
7.7 The Indian Market
8. LEADING COMPANIES IN ADVANCED WOUND CARE MARKET, 2012-2023
8.1 Leading Companies, 2011
8.2 Kinetic Concepts Inc (KCI)
8.2.1 Apax Partners' Led Consortium Acquires KCI for $6.3bn
8.2.2 Success of VAC Therapy
8.2.3 KCI Expands its Operations
8.3 Smith & Nephew (S&N)
8.3.1 Sales and Performance Analysis, 2011
8.3.2 Regional Breakdown, 2011
8.3.3 Smith & Nephew Advanced Wound Care Sales. 2011
8.3.4 Advanced Wound Management Sales by Region, 2011
8.3.5 Smith & Nephew Pipeline
8.3.6 Smith & Nephew Acquires Kalypto Medical
8.4 Molnlycke Health Care
8.4.1 Molnlycke Sales, 2011
8.4.2 Recent Acquisitions
8.4.2.1 Molnlycke Acquires WoundEL from Gerromed GmbH
8.4.2.2 Molnlycke Acquires Burn and Wound Care Business of Brennen Medical
8.5 ConvaTec
8.5.1 Sales and Performance Analysis, 2011
8.5.2 ConvaTec Advanced Wound Care Sales, 2011
8.5.3 Regional Breakdown, 2011
8.5.4 ConvaTec Research & Development
8.6 Systagenix Wound Management
8.6.1 Systagenix Acquires O2 Insights Inc
8.7 Coloplast
8.7.1 Coloplast Sales and Performance Analysis, 2011
8.7.2 Regional Breakdown, 2011
8.7.3 Coloplast Advanced Wound Care Sales, 2010/2011
8.8 Other Companies, 2011
9. EXPERT OPINION
9.1 Interview with Derma Sciences
9.1.1 Perspective of Advanced Wound Care Market
9.1.2 Unmet needs of the Industry
9.1.3 Do FDA Regulations Stifle Innovation?
9.1.4 Role of Moist Wound Care in the Future
9.1.5 Market for MEDIHONEY in Moist Wound Care
9.1.6 Key Products Driving Company Growth
9.1.7 Efficacy of Honey in Comparison to Silver
9.2 Interview with Shire Regenerative Medicine
9.2.1 Perspective of Wound Care Biologics Market
9.2.2 Cost and Reimbursement Issues
9.2.3 Outlook for Dermagraft
10. ADVANCED WOUND CARE MARKET, 2012-2023
10.1 Advanced Wound Care Market, 2012-2023
10.1.1 Growth will be driven by an Increasing Prevalence of Chronic Wounds
10.1.2 Emerging Markets will Drive Growth
10.2 The Moist Wound Care Market
10.3 The Wound Care Devices Market
10.4 The Wound Care Biologics Market
LIST OF TABLES
Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification System
Table 2.2 The Classification of Burns by Depth: Degree Classification System
Table 2.3 The Classification of Burns by Severity
Table 2.4 The Advantages and Disadvantages of Moist Wound Care
Table 2.5 The Benefits and Risks of Skin Grafting
Table 3.1 Medical Device Market: Global Revenue ($bn) and Market Shares (%) by Sector, 2011
Table 3.2 Global Wound Care Market: Revenue ($bn) and Market Shares (%) by Sector, 2011
Table 3.3 The Advanced Wound Care Market: Revenue ($bn) and Market Shares (%) by Segment, 2011
Table 3.4 The Advanced Wound Care Market Forecast ($bn, %), 2011-2023
Table 3.5 Drivers and Restraints for the Advanced Wound Care Market, 2012-2023
Table 4.1 The Moist Wound Care Market: Revenue ($bn) and Market Share (%) by Segments, 2011
Table 4.2 The Moist Wound Care Market Forecast ($bn, %), 2011-2017
Table 4.3 The Moist Wound Care Market Forecast ($bn, %), 2017-2023
Table 4.4 Leading Products in Hydrocolloid Dressing Market, 2011
Table 4.5 Leading Products in the Foam Dressing Market, 2011
Table 4.6 Leading Products in the Alginate Dressing Market, 2011
Table 4.7 Leading Products in the Hydrogel Dressing Market, 2011
Table 4.8 Moist Wound Care Products Pipeline, 2011
Table 4.9 SWOT Analysis of the Moist Wound Care Market, 2012-2023
Table 5.1 The Wound Care Device Market: Revenue ($bn) and Market Share (%) by Segments, 2011
Table 5.2 The Wound Care Devices Market Forecast ($bn, %), 2011-2017
Table 5.3 The Wound Care Devices Market Forecast ($bn, %), 2017-2023
Table 5.4 The NPWT Market Forecast ($bn, %), 2011-2017
Table 5.5 The NPWT Market Forecast ($bn, %), 2017-2023
Table 5.6 Drivers and Restraints in the NPWT Market, 2012-2023
Table 5.7 Leading Products in the Ultrasound Wound Therapy Market, 2011
Table 5.8 Leading Products in the Electrical Stimulation Market, 2011
Table 5.9 Wound Care Devices Development Pipeline, 2011
Table 5.10 SWOT Analysis of the Wound Care Devices Market, 2012-2023
Table 6.1 The Wound Care Biologics Market: Revenue ($bn) and Market Shares (%) by Segments, 2011
Table 6.2 The Wound Care Biologics Market Forecast ($bn, %), 2011-2017
Table 6.3 The Wound Care Biologics Market Forecast ($bn, %), 2017-2023
Table 6.4 Drivers and Restraints in the Biologics Market, 2012-2023
Table 6.5 Other Leading Products in the Skin Replacement Market, 2011
Table 6.6 The Skin Replacement Market Forecast ($bn, %), 2011-2017
Table 6.7 The Skin Replacement Market Forecast ($bn, %), 2017-2023
Table 6.8 Leading Products in the Collagen Based Therapy Market, 2011
Table 6.9 The Collagen Based Therapy Market Forecast ($bn, %), 2011-2017
Table 6.10 The Collagen Based Therapy Market Forecast ($bn, %), 2017-2023
Table 6.11 Leading Products in the Cell Therapy Market, 2011
Table 6.12 The Cell Therapy Market Forecast ($bn, %), 2011-2017
Table 6.13 The Cell Therapy Market Forecast ($bn, %), 2017-2023
Table 6.14 Other Leading Biologic Products in the Market, 2011
Table 6.15 The Wound Care Biologics Development Pipeline, 2011
Table 6.16 SWOT Analysis of the Wound Care Biologics Market, 2012-2023
Table 7.1 Leading National Markets for Advanced Wound Care ($bn) and Market Shares (%), 2011
Table 7.2 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2011-2017
Table 7.3 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2017-2023
Table 7.4 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011
Table 7.5 The European Advanced Wound Care Market Forecast ($bn, %) by leading Countries 2011-2017
Table 7.6 The European Advanced Wound Care Market Forecast ($bn, %) by leading Countries 2017-2023
Table 7.7 Chinese Advanced Wound Care Market: Drivers and Restraints, 2012-2023
Table 8.1 Leading Companies in the AWC Market: Revenue ($bn) and Market Shares (%), 2011
Table 8.2 VAC Therapy at a Glance, 2011
Table 8.3 Smith & Nephew Revenue ($bn) and Market Shares (%) by Business Segments, 2011
Table 8.4 Smith & Nephew Market Shares (%) by Region, 2011
Table 8.5 Smith & Nephew Advanced Wound Management Sales ($bn) by Region, 2011
Table 8.6 ConvaTec: Revenue ($m) and Market Share (%) by Business Segments, 2011
Table 8.7 ConvaTec Sales ($m) by Region, Revenue ($m) and Market Shares (%) 2011
Table 8.8 Coloplast: Revenue ($bn) and Market Share (%) by Segments, 2010/2011
Table 8.9 Coloplast Sales ($bn) by Region, 2010/2011
Table 8.10 Other Companies in Advanced Wound Care Market, 2011
Table 10.1 Global Advanced Wound Care Market: Drivers and Restraints, 2012-2023
Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification System
Table 2.2 The Classification of Burns by Depth: Degree Classification System
Table 2.3 The Classification of Burns by Severity
Table 2.4 The Advantages and Disadvantages of Moist Wound Care
Table 2.5 The Benefits and Risks of Skin Grafting
Table 3.1 Medical Device Market: Global Revenue ($bn) and Market Shares (%) by Sector, 2011
Table 3.2 Global Wound Care Market: Revenue ($bn) and Market Shares (%) by Sector, 2011
Table 3.3 The Advanced Wound Care Market: Revenue ($bn) and Market Shares (%) by Segment, 2011
Table 3.4 The Advanced Wound Care Market Forecast ($bn, %), 2011-2023
Table 3.5 Drivers and Restraints for the Advanced Wound Care Market, 2012-2023
Table 4.1 The Moist Wound Care Market: Revenue ($bn) and Market Share (%) by Segments, 2011
Table 4.2 The Moist Wound Care Market Forecast ($bn, %), 2011-2017
Table 4.3 The Moist Wound Care Market Forecast ($bn, %), 2017-2023
Table 4.4 Leading Products in Hydrocolloid Dressing Market, 2011
Table 4.5 Leading Products in the Foam Dressing Market, 2011
Table 4.6 Leading Products in the Alginate Dressing Market, 2011
Table 4.7 Leading Products in the Hydrogel Dressing Market, 2011
Table 4.8 Moist Wound Care Products Pipeline, 2011
Table 4.9 SWOT Analysis of the Moist Wound Care Market, 2012-2023
Table 5.1 The Wound Care Device Market: Revenue ($bn) and Market Share (%) by Segments, 2011
Table 5.2 The Wound Care Devices Market Forecast ($bn, %), 2011-2017
Table 5.3 The Wound Care Devices Market Forecast ($bn, %), 2017-2023
Table 5.4 The NPWT Market Forecast ($bn, %), 2011-2017
Table 5.5 The NPWT Market Forecast ($bn, %), 2017-2023
Table 5.6 Drivers and Restraints in the NPWT Market, 2012-2023
Table 5.7 Leading Products in the Ultrasound Wound Therapy Market, 2011
Table 5.8 Leading Products in the Electrical Stimulation Market, 2011
Table 5.9 Wound Care Devices Development Pipeline, 2011
Table 5.10 SWOT Analysis of the Wound Care Devices Market, 2012-2023
Table 6.1 The Wound Care Biologics Market: Revenue ($bn) and Market Shares (%) by Segments, 2011
Table 6.2 The Wound Care Biologics Market Forecast ($bn, %), 2011-2017
Table 6.3 The Wound Care Biologics Market Forecast ($bn, %), 2017-2023
Table 6.4 Drivers and Restraints in the Biologics Market, 2012-2023
Table 6.5 Other Leading Products in the Skin Replacement Market, 2011
Table 6.6 The Skin Replacement Market Forecast ($bn, %), 2011-2017
Table 6.7 The Skin Replacement Market Forecast ($bn, %), 2017-2023
Table 6.8 Leading Products in the Collagen Based Therapy Market, 2011
Table 6.9 The Collagen Based Therapy Market Forecast ($bn, %), 2011-2017
Table 6.10 The Collagen Based Therapy Market Forecast ($bn, %), 2017-2023
Table 6.11 Leading Products in the Cell Therapy Market, 2011
Table 6.12 The Cell Therapy Market Forecast ($bn, %), 2011-2017
Table 6.13 The Cell Therapy Market Forecast ($bn, %), 2017-2023
Table 6.14 Other Leading Biologic Products in the Market, 2011
Table 6.15 The Wound Care Biologics Development Pipeline, 2011
Table 6.16 SWOT Analysis of the Wound Care Biologics Market, 2012-2023
Table 7.1 Leading National Markets for Advanced Wound Care ($bn) and Market Shares (%), 2011
Table 7.2 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2011-2017
Table 7.3 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2017-2023
Table 7.4 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011
Table 7.5 The European Advanced Wound Care Market Forecast ($bn, %) by leading Countries 2011-2017
Table 7.6 The European Advanced Wound Care Market Forecast ($bn, %) by leading Countries 2017-2023
Table 7.7 Chinese Advanced Wound Care Market: Drivers and Restraints, 2012-2023
Table 8.1 Leading Companies in the AWC Market: Revenue ($bn) and Market Shares (%), 2011
Table 8.2 VAC Therapy at a Glance, 2011
Table 8.3 Smith & Nephew Revenue ($bn) and Market Shares (%) by Business Segments, 2011
Table 8.4 Smith & Nephew Market Shares (%) by Region, 2011
Table 8.5 Smith & Nephew Advanced Wound Management Sales ($bn) by Region, 2011
Table 8.6 ConvaTec: Revenue ($m) and Market Share (%) by Business Segments, 2011
Table 8.7 ConvaTec Sales ($m) by Region, Revenue ($m) and Market Shares (%) 2011
Table 8.8 Coloplast: Revenue ($bn) and Market Share (%) by Segments, 2010/2011
Table 8.9 Coloplast Sales ($bn) by Region, 2010/2011
Table 8.10 Other Companies in Advanced Wound Care Market, 2011
Table 10.1 Global Advanced Wound Care Market: Drivers and Restraints, 2012-2023
LIST OF FIGURES
Figure 2.1 The Phases of Wound Healing and Duration (Days)
Figure 3.1 Medical Device Market: Global Revenue ($bn) by Sector, 2011
Figure 3.2 Medical Device Market: Market Share(%) by Sector, 2011
Figure 3.3 Global Wound Care Market: Revenue ($bn) by Sector, 2011
Figure 3.4 Global Wound Care Market: Market Shares (%) by Sector, 2011
Figure 3.5 The Advanced Wound Care Market: Revenue ($bn) by Segment, 2011
Figure 3.6 The Advanced Wound Care Market: Market Share (%) by Segment, 2011
Figure 3.7 The Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 4.1 The Moist Wound Care Market: Revenue ($bn) by Segments, 2011
Figure 4.2 The Moist Wound Care Market: Market Share (%) by Segments, 2011
Figure 4.3 Total Moist Wound Care Market Forecast ($bn), 2011-2023
Figure 5.1 The Wound Care Devices: Revenue ($bn) by Segments, 2011
Figure 5.2 The Wound Care Devices: Market Share (%) by Segments, 2011
Figure 5.3 Total Wound Care Devices Market Forecast ($bn), 2011-2023
Figure 5.4 NPWT Wound Therapy Devices Market Forecast ($bn), 2011-2023
Figure 5.5 Ultrasound Wound Therapy Market Forecast ($bn), 2011-2023
Figure 5.6 The NPWT Market Forecast: Revenue ($bn), 2011-2017
Figure 5.7 The NPWT Market Forecast ($bn), 2017-2023
Figure 6.1 The Wound Care Biologics Market: Revenue ($bn) by Segments, 2011
Figure 6.2 The Wound Care Biologics Market: Market Shares (%) by Segments, 2011
Figure 6.3 The Biologics Market Forecast ($bn), 2011-2023
Figure 6.4 The Skin Replacement Market Forecast ($bn), 2011-2017
Figure 6.5 The Skin Replacement Market Forecast ($bn), 2017-2023
Figure 6.6 The Collagen Based Therapy Market Forecast ($bn), 2011-2017
Figure 6.7 The Collagen Based Therapy Market Forecast ($bn), 2017-2023
Figure 6.8 The Cell Therapy Market Forecast ($bn), 2011-2017
Figure 6.9 The Cell Therapy Market Forecast ($bn), 2017-2023
Figure 7.1 The Advanced Wound Care Market: Revenue ($bn) in Leading National Markets, 2011
Figure 7.2 The Advanced Wound Care Market: Market Shares (%) in Leading National Markets, 2011
Figure 7.3 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2011-2023
Figure 7.4 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011
Figure 7.5 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011
Figure 7.6 The European Advanced Wound Care Market Forecast ($bn) 2011-2023
Figure 7.7 The Advanced Wound Care Market Forecast ($bn) in Germany & France, 2011-2023
Figure 7.8 UK Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.9 Spanish Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.10 Italian Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.11 Japanese Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.12 Chinese Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.13 Indian Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 8.1 Leading Companies in the AWC Market: Revenue ($bn), 2011
Figure 8.2 Leading Companies in the AWC Market: Market Shares (%), 2011
Figure 8.3 Smith & Nephew: Revenue ($bn) by Segments, 2011
Figure 8.4 Smith & Nephew: Market Shares (%) by Segments, 2011
Figure 8.5 Smith & Nephew: Market Shares (%) by Region, 2011
Figure 8.6 Smith & Nephew Advanced Wound Management Sales: Market Share (%) by Region, 2011
Figure 8.7 ConvaTec: Market Share (%) by Business Segment, 2011
Figure 8.8 ConvaTec: Revenue ($m) by Business Segment, 2011
Figure 8.9 ConvaTec Market Shares (%) by Region, 2011
Figure 8.10 Coloplast: Revenue ($bn) by Segments, 2010/2011
Figure 8.11 Coloplast: Market Share (%) by Segments, 2011/2012
Figure 8.12 Coloplast Market Share (%) by Region, 2010/2011
COMPANIES LISTED
3M
Acell
AcryMed
Activa Health Care
Advanced Medical Solutions
Agennix
Anika Therapeutics
AOTI
Argentum Medical
ArjoHuntleigh
Armed Forces Institute of Regenerative Medicine (AFIRM)
Arobella Medical
Avita Medical
Biofisica
Biolight AB
B.Braun
Boehringer Ingelheim
Brennen Medical
BSN Medical Gmbh
Cardium Therapeutics
Catrix
Celleration
Centre for Devices and Radiological Health (CDRH)
Collagen Matrix
Coloplast
ConvaTec
Cornell University
Covalon Technologies
Covidien
Curatec
Curasan
Cytomedix
Derma Sciences
Deroyal
Devon Medical Products
Diapulse Corporation of America
Dr. Suwelack Skin & Healthcare
Dow-Hickam
Eucare Pharmaceuticals
Ferris
Fibrogen
Fidia Advanced Biopolymers
Food and Drug Administration (FDA)
Forticell Bioscience
Fraunhofer Institute
Garnet Biotherapeutics
Genadyne Biotechnologies
Genzyme Biosurgery
Getinge
Greystone Pharmaceuticals
Hartmann Group
Healthpoint Biotherapeutics
HemCon Medical Technologies
Hollister Wound Care
Human Biosciences
HydroFera
Innovative Therapies
Ingenious Technologies Corporation
Integra Life Science Corp
International Diabetic Federation (IDF)
Innocoll
Italian National Health Service
IYIA Technologies
Johnson & Johnson
Kaken Pharmaceuticals
Kalypto Medical
Kinetic Concepts
Kuros Biosurgery
Lifecell
Lightwave Technologies
Lescarden
Lohmann & Rauscher
Macrocure
Marine Polymer Technologies Inc
McGowan Institute for Regenerative Medicine
Medestea Internazionale
MediWound
Medline Industries
MiMedX
Ministry of Health, Labour and Welfare (MHLW)
Misonix
Missouri S&T and Mo-Sci Corporation
Molnlycke
Nara University, Japan
National Competent Authorities (NCA)
National Health Service (NHS)
Nanotherapeutics
NanoVibronix
Noble Biomaterials
Oculus Innovative Sciences
Organogenesis
Osiris Therapeutics
Oxygen Biotherapeutics
Phytoceuticals
Polyheal
Polynovo Biomaterials
Promethean LifeSciences
Prospera
Quick Med Technologies
RedDress
RegeneRx Biopharmaceuticals
Regenesis Biomedical
SafeBlood Technologies
Sangui BioTech International
Sanuwave Health
Shire Regenerative Medicine
Smith & Nephew
Soring
Spiracur
Synapse Microcurrent
Snyder Wound Research LLC
Systagenix
Talley Group
Tissue Genesis
Tissue Regeneration Technologies
UC, Berkley
UDL Laboratories
ULURU
United Nations (UN)
University of Cincinnati
University of Bath
URGO
Vibrant Medical
Vario
Vomaris Innovations
Wellman Centre for Photomedicine, Harvard University
Wound Management Technologies
Wright Medical
Figure 2.1 The Phases of Wound Healing and Duration (Days)
Figure 3.1 Medical Device Market: Global Revenue ($bn) by Sector, 2011
Figure 3.2 Medical Device Market: Market Share(%) by Sector, 2011
Figure 3.3 Global Wound Care Market: Revenue ($bn) by Sector, 2011
Figure 3.4 Global Wound Care Market: Market Shares (%) by Sector, 2011
Figure 3.5 The Advanced Wound Care Market: Revenue ($bn) by Segment, 2011
Figure 3.6 The Advanced Wound Care Market: Market Share (%) by Segment, 2011
Figure 3.7 The Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 4.1 The Moist Wound Care Market: Revenue ($bn) by Segments, 2011
Figure 4.2 The Moist Wound Care Market: Market Share (%) by Segments, 2011
Figure 4.3 Total Moist Wound Care Market Forecast ($bn), 2011-2023
Figure 5.1 The Wound Care Devices: Revenue ($bn) by Segments, 2011
Figure 5.2 The Wound Care Devices: Market Share (%) by Segments, 2011
Figure 5.3 Total Wound Care Devices Market Forecast ($bn), 2011-2023
Figure 5.4 NPWT Wound Therapy Devices Market Forecast ($bn), 2011-2023
Figure 5.5 Ultrasound Wound Therapy Market Forecast ($bn), 2011-2023
Figure 5.6 The NPWT Market Forecast: Revenue ($bn), 2011-2017
Figure 5.7 The NPWT Market Forecast ($bn), 2017-2023
Figure 6.1 The Wound Care Biologics Market: Revenue ($bn) by Segments, 2011
Figure 6.2 The Wound Care Biologics Market: Market Shares (%) by Segments, 2011
Figure 6.3 The Biologics Market Forecast ($bn), 2011-2023
Figure 6.4 The Skin Replacement Market Forecast ($bn), 2011-2017
Figure 6.5 The Skin Replacement Market Forecast ($bn), 2017-2023
Figure 6.6 The Collagen Based Therapy Market Forecast ($bn), 2011-2017
Figure 6.7 The Collagen Based Therapy Market Forecast ($bn), 2017-2023
Figure 6.8 The Cell Therapy Market Forecast ($bn), 2011-2017
Figure 6.9 The Cell Therapy Market Forecast ($bn), 2017-2023
Figure 7.1 The Advanced Wound Care Market: Revenue ($bn) in Leading National Markets, 2011
Figure 7.2 The Advanced Wound Care Market: Market Shares (%) in Leading National Markets, 2011
Figure 7.3 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2011-2023
Figure 7.4 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011
Figure 7.5 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011
Figure 7.6 The European Advanced Wound Care Market Forecast ($bn) 2011-2023
Figure 7.7 The Advanced Wound Care Market Forecast ($bn) in Germany & France, 2011-2023
Figure 7.8 UK Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.9 Spanish Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.10 Italian Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.11 Japanese Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.12 Chinese Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 7.13 Indian Advanced Wound Care Market Forecast ($bn), 2011-2023
Figure 8.1 Leading Companies in the AWC Market: Revenue ($bn), 2011
Figure 8.2 Leading Companies in the AWC Market: Market Shares (%), 2011
Figure 8.3 Smith & Nephew: Revenue ($bn) by Segments, 2011
Figure 8.4 Smith & Nephew: Market Shares (%) by Segments, 2011
Figure 8.5 Smith & Nephew: Market Shares (%) by Region, 2011
Figure 8.6 Smith & Nephew Advanced Wound Management Sales: Market Share (%) by Region, 2011
Figure 8.7 ConvaTec: Market Share (%) by Business Segment, 2011
Figure 8.8 ConvaTec: Revenue ($m) by Business Segment, 2011
Figure 8.9 ConvaTec Market Shares (%) by Region, 2011
Figure 8.10 Coloplast: Revenue ($bn) by Segments, 2010/2011
Figure 8.11 Coloplast: Market Share (%) by Segments, 2011/2012
Figure 8.12 Coloplast Market Share (%) by Region, 2010/2011
COMPANIES LISTED
3M
Acell
AcryMed
Activa Health Care
Advanced Medical Solutions
Agennix
Anika Therapeutics
AOTI
Argentum Medical
ArjoHuntleigh
Armed Forces Institute of Regenerative Medicine (AFIRM)
Arobella Medical
Avita Medical
Biofisica
Biolight AB
B.Braun
Boehringer Ingelheim
Brennen Medical
BSN Medical Gmbh
Cardium Therapeutics
Catrix
Celleration
Centre for Devices and Radiological Health (CDRH)
Collagen Matrix
Coloplast
ConvaTec
Cornell University
Covalon Technologies
Covidien
Curatec
Curasan
Cytomedix
Derma Sciences
Deroyal
Devon Medical Products
Diapulse Corporation of America
Dr. Suwelack Skin & Healthcare
Dow-Hickam
Eucare Pharmaceuticals
Ferris
Fibrogen
Fidia Advanced Biopolymers
Food and Drug Administration (FDA)
Forticell Bioscience
Fraunhofer Institute
Garnet Biotherapeutics
Genadyne Biotechnologies
Genzyme Biosurgery
Getinge
Greystone Pharmaceuticals
Hartmann Group
Healthpoint Biotherapeutics
HemCon Medical Technologies
Hollister Wound Care
Human Biosciences
HydroFera
Innovative Therapies
Ingenious Technologies Corporation
Integra Life Science Corp
International Diabetic Federation (IDF)
Innocoll
Italian National Health Service
IYIA Technologies
Johnson & Johnson
Kaken Pharmaceuticals
Kalypto Medical
Kinetic Concepts
Kuros Biosurgery
Lifecell
Lightwave Technologies
Lescarden
Lohmann & Rauscher
Macrocure
Marine Polymer Technologies Inc
McGowan Institute for Regenerative Medicine
Medestea Internazionale
MediWound
Medline Industries
MiMedX
Ministry of Health, Labour and Welfare (MHLW)
Misonix
Missouri S&T and Mo-Sci Corporation
Molnlycke
Nara University, Japan
National Competent Authorities (NCA)
National Health Service (NHS)
Nanotherapeutics
NanoVibronix
Noble Biomaterials
Oculus Innovative Sciences
Organogenesis
Osiris Therapeutics
Oxygen Biotherapeutics
Phytoceuticals
Polyheal
Polynovo Biomaterials
Promethean LifeSciences
Prospera
Quick Med Technologies
RedDress
RegeneRx Biopharmaceuticals
Regenesis Biomedical
SafeBlood Technologies
Sangui BioTech International
Sanuwave Health
Shire Regenerative Medicine
Smith & Nephew
Soring
Spiracur
Synapse Microcurrent
Snyder Wound Research LLC
Systagenix
Talley Group
Tissue Genesis
Tissue Regeneration Technologies
UC, Berkley
UDL Laboratories
ULURU
United Nations (UN)
University of Cincinnati
University of Bath
URGO
Vibrant Medical
Vario
Vomaris Innovations
Wellman Centre for Photomedicine, Harvard University
Wound Management Technologies
Wright Medical
